M.D. García-Vázquez

Author

M.D. García-Vázquez

Also Known As

M D Garcia-Vazquez, M D Garcia-Vázquez, M D García-Vázquez, M. Garcia-Vazquez, M.D. García-Vázquez, María D. García‐Vázquez, María Dolores García-Vazquez, María Dolores García-Vázquez, María Dolores García‐Vazquez

Publications

203

Citations

H-Index

Concepts

All Affiliations

University of the Basque Country Hospital de Cruces BioCruces Health research Institute

About

M.D. García-Vázquez is an author at University of the Basque Country specializing in tumor microenvironment, inflammation, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	34
2	Immunology	2	2	34
3	Cell Biology	1	1	11
4	Pathology	1	1	23
5	Cancer Cell Biology	1	1	11

M.D. García-Vázquez

Publications

193

Citations

H-Index

Page 1

	Year	Citations
Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma María Dolores Boyano, M.D. García-Vázquez, T López-Michelena, British Journal of Cancer	2000	92
Vitronectin and dermcidin serum levels predict the metastatic progression of <scp>AJCC I–II</scp> early‐stage melanoma Idoia Ortega‐Martínez, Jesús Gardeazábal, Asier Erramuzpe, International Journal of Cancer	2016	39
Serum markers improve current prediction of metastasis development in early‐stage melanoma patients: a machine learning‐based study Filippo Mancuso, Sergio Lage, Javier Rasero, Molecular Oncology	2020	28
Serum-Soluble IL-2 Receptor and IL-6 Levels in Patients with Melanoma María Dolores Boyano, M.D. García-Vázquez, Jesús Gardeazábal, Oncology InflammationCytokineSkin CancerMedicineMelanoma	1997	23
Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours. M.D. García-Vázquez, María Dolores Boyano, M Cañavate, PubMed ImmunologyRms Cell LinesImmunotherapyCancer BiologyTumor Biology	2000	11

Page 1